Abingdon Health and University of Birmingham to invest £2 million in Joint Venture
Bioscience Ventures combines the research and clinical capabilities of the University with the commercial management expertise of Abingdon Health
Bioscience Ventures combines the research and clinical capabilities of the University with the commercial management expertise of Abingdon Health
Scientists at the University of Birmingham have developed a ground-breaking technique that uses a urine test to help to diagnose adrenal cancer.